SerImmune

About:

Serimmune is a company that studies immunity to find out how environmental factors affect health and disease.

Website: https://www.serimmune.com/

Twitter/X: serimmune

Top Investors: Merck, Illumina Ventures

Description:

Serimmune is a company that studies immunity to find out how environmental factors affect health and disease. Its universal serology platform utilizes bacterial display peptide library technology and sequencing to broadly profile antibody repertoires and identify antigens and epitopes associated with many diseases all in a single assay.

Total Funding Amount:

$21.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Goleta, California, United States

Founded Date:

2014-01-01

Contact Email:

Info(AT)serimmune.com

Founders:

Patrick Daugherty

Number of Employees:

11-50

Last Funding Date:

2020-09-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai